Caris Life Sciences
PublicCaris Life Sciences is now publicly traded
The data on this page reflects Caris Life Sciences's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jun 17, 2025
Last Round
Growth Equity
Apr 7, 2025
Total Funding Raised
$2.12B
Company Overview
Caris Life Sciences is a biotechnology company that provides precision medicine solutions through molecular profiling and artificial intelligence to support cancer treatment decisions.
Sector
Biotech
AI Layer
Application
Keywords
Caris Life Sciences Comparables
Compare Caris Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tempus | 90% | |
| Guardant Health | 87% | |
| Personalis Inc | 79% |
Caris Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jun 17, 2025 | ||||
| Growth Equity | Apr 7, 2025 | ||||
| Debt | Jan 19, 2023 | ||||
| Growth Equity | May 11, 2021 | ||||
| Debt | Oct 27, 2020 | ||||
Debt | Oct 1, 2018 |
Caris Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CPP Investments | Growth Equity |
| Evercore ISI | ipo |
| Perceptive Advisors | Growth Equity |
| Guggenheim Securities | ipo |
| Millennium Management | Growth Equity, Debt |
| Braidwell | Debt, Growth Equity |
| Columbia Threadneedle Investments | Growth Equity |
Recent news
Latest coverage and updates
- has_valuationOct 20, 2026
Caris Life Sciences, Inc. reaches a $10.3B market cap after going public in Mar '25.
- attends_eventOct 14, 2026
Caris Life Sciences is to present eight studies at ESMO 2026 in Spain in Oct '26, highlighting AI, multi-omics and precision medicine across multiple cancer types.
- attends_eventOct 14, 2026
Caris Life Sciences researchers are set to present eight posters at the European Society for Medical Oncology (ESMO) Congress 2026 from Oct 23rd to 27th '26 in Spain.
- attends_eventOct 5, 2026
Caris Life Sciences, Inc. sponsors the Breast Cancer Awareness Symposium 2026, an educational and networking event hosted by Texas Oncology, in Texas on Oct 16th '26.
- launchesSep 29, 2026
Caris Life Sciences, Inc. unveiled enhanced Caris Assure, a new liquid biopsy platform integrating whole exome sequencing, whole transcriptome sequencing, and whole-blood analysis to provide a more complete molecular profile from a single blood draw, in Texas on Sep 29th '26.
Caris Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access